Jackson Square Partners, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jackson Square Partners, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2020$205,825,000
+14.9%
2,298,190
+27.8%
1.03%
-8.7%
Q1 2020$179,163,000
-12.3%
1,797,743
+1.1%
1.13%
+5.5%
Q4 2019$204,403,000
-5.6%
1,778,966
+3.6%
1.07%
-9.9%
Q3 2019$216,563,000
-8.0%
1,716,851
-12.2%
1.19%
-2.4%
Q2 2019$235,339,000
+62.5%
1,955,625
+18.1%
1.22%
+53.7%
Q1 2019$144,838,000
-1.4%
1,655,676
+12.8%
0.79%
-12.0%
Q4 2018$146,845,000
-10.9%
1,467,726
+2.0%
0.90%
+8.2%
Q3 2018$164,899,000
+47.7%
1,439,167
+15.6%
0.83%
+46.1%
Q2 2018$111,662,0001,245,1220.57%
Other shareholders
HAEMONETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders